Search research articles
Contact Us
Filters
Showing results (21-30 of 57) with videos related to
Page
of 6
Sort By:
Cancer Immunology Research
|
May 20, 2016
Molecular Drivers of the Non-T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder Cancer
Randy F Sweis, Stefani Spranger, Riyue Bao, et al.
Journal for Immunotherapy of Cancer
|
April 6, 2018
Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer
Randy F Sweis, Yuanyuan Zha, Lomax Pass, et al.
Frontiers in Immunology
|
March 22, 2024
Dysregulated FGFR3 signaling alters the immune landscape in bladder cancer and presents therapeutic possibilities in an agent-based model
Daniel R Bergman, Yixuan Wang, Erica Trujillo, et al.
Annals of Internal Medicine
|
October 21, 2014
Do clinicians know which of their patients have central venous catheters?: a multicenter observational study
Vineet Chopra, Sushant Govindan, Latoya Kuhn, et al.
Cancers
|
September 14, 2024
Agent-Based Modeling of Virtual Tumors Reveals the Critical Influence of Microenvironmental Complexity on Immunotherapy Efficacy
Yixuan Wang, Daniel R Bergman, Erica Trujillo, et al.
Investigational New Drugs
|
February 19, 2024
A phase 1b open-label study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of py314 in combination with pembrolizumab in patients with advanced renal cell carcinoma
Kathryn E Beckermann, Amita Patnaik, Ira Winer, et al.
Cancer Immunology Research
|
January 14, 2025
PKCδ Germline Variants and Genetic Deletion in Mice Augment Antitumor Immunity through Regulation of Myeloid Cells
Kyle R Cron, Ayelet Sivan, Keston Aquino-Michaels, et al.
Clinical Genitourinary Cancer
|
September 17, 2016
Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Pharmacodynamic Biomarker for Pazopanib in Metastatic Renal Carcinoma
Randy F Sweis, Milica Medved, Shannon Towey, et al.
Clinical Genitourinary Cancer
|
November 6, 2018
Safety and Efficacy of Hypofractionated Radiotherapy With Capecitabine in Elderly Patients With Urothelial Carcinoma
Jim Leng, Adil S Akthar, Russell Z Szmulewitz, et al.
Clinical Genitourinary Cancer
|
January 16, 2024
Bladder-Preserving Trimodality Therapy With Capecitabine
Connor Lynch, Randy F Sweis, Parth Modi, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 57) with videos related to
Sort By:
Page
of 6
Cancer Immunology Research
|
May 20, 2016
Molecular Drivers of the Non-T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder Cancer
Randy F Sweis, Stefani Spranger, Riyue Bao, et al.
Journal for Immunotherapy of Cancer
|
April 6, 2018
Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer
Randy F Sweis, Yuanyuan Zha, Lomax Pass, et al.
Frontiers in Immunology
|
March 22, 2024
Dysregulated FGFR3 signaling alters the immune landscape in bladder cancer and presents therapeutic possibilities in an agent-based model
Daniel R Bergman, Yixuan Wang, Erica Trujillo, et al.
Annals of Internal Medicine
|
October 21, 2014
Do clinicians know which of their patients have central venous catheters?: a multicenter observational study
Vineet Chopra, Sushant Govindan, Latoya Kuhn, et al.
Cancers
|
September 14, 2024
Agent-Based Modeling of Virtual Tumors Reveals the Critical Influence of Microenvironmental Complexity on Immunotherapy Efficacy
Yixuan Wang, Daniel R Bergman, Erica Trujillo, et al.
Investigational New Drugs
|
February 19, 2024
A phase 1b open-label study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of py314 in combination with pembrolizumab in patients with advanced renal cell carcinoma
Kathryn E Beckermann, Amita Patnaik, Ira Winer, et al.
Cancer Immunology Research
|
January 14, 2025
PKCδ Germline Variants and Genetic Deletion in Mice Augment Antitumor Immunity through Regulation of Myeloid Cells
Kyle R Cron, Ayelet Sivan, Keston Aquino-Michaels, et al.
Clinical Genitourinary Cancer
|
September 17, 2016
Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Pharmacodynamic Biomarker for Pazopanib in Metastatic Renal Carcinoma
Randy F Sweis, Milica Medved, Shannon Towey, et al.
Clinical Genitourinary Cancer
|
November 6, 2018
Safety and Efficacy of Hypofractionated Radiotherapy With Capecitabine in Elderly Patients With Urothelial Carcinoma
Jim Leng, Adil S Akthar, Russell Z Szmulewitz, et al.
Clinical Genitourinary Cancer
|
January 16, 2024
Bladder-Preserving Trimodality Therapy With Capecitabine
Connor Lynch, Randy F Sweis, Parth Modi, et al.
Page
of 6